Io biotech announces participation in cowen 6th annual oncology innovation summit and jefferies global healthcare conference

New york, may 20, 2025 (globe newswire) -- io biotech (nasdaq: iobt), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that mai-britt zocca, phd, the company's president and ceo, along with amy sullivan, the company's cfo, and qasim ahmad, md, the company's cmo, will be participating in a fireside chat at the td cowen 6th annual oncology summit: insights for asco & eha being held virtually may 27-28, 2025. additionally, dr. zocca will be presenting and dr. zocca, amy sullivan, and dr. ahmad will be participating in one-on-one investor meetings at the jefferies global healthcare conference to be held june 3-5, 2025 in new york, ny.
COWN Ratings Summary
COWN Quant Ranking